近年来人工晶状体(Intraocular lens,IOL)领域蓬勃发展,散光矫正型人工晶状体(Toric IOL)为白内障合并低度角膜散光的患者提供了一项“一举两得”的可靠解决方案。众所周知,IOL植入术后,无特殊情况IOL应终身留在患者眼中,因此术后的远期视...
One version of this product, the AcrySof IQ Vivity Toric Extended Vision IOL, will also correct for astigmatism. In clinical trials, patients reported high satisfaction and outstanding outcomes with AcrySof IQ Vivity IOLs. In one study, 94 percent of participants rated visual acuity at distances...
AcrySof™ IQ and Toric IOL Clinical Studies Gunderson KG & Potvin R. Comparing visual acuity, low contrast acuity and refractive error after implantation of a low cylinder power toric intraocular lens or a non-toric intraocular lens Comparing uncorrected and best-corrected visual acuity, low...
Evaluating visual performance after implantation of a quadrifocal intraocular lens (IOL). Kohnen T, et al. Presbyopia correction in astigmatic eyes using a toric trifocal intraocular lens with quadrifocal technology Clinically evaluating the visual performance of the AcrySof® IQ PanOptix® TFNT00...
A:Kaufer医生和Murta医生表示,以前植入其他多焦点IOL的患者会抱怨晚上看书或开车视力受限,但植入PanOptix的患者很少抱怨在暗光条件下视物受限。 Braga-Mele医生解释,PanOptix不像其他多焦点IOL那样依赖瞳孔或照明,它可以在各种条件下提供功能性视觉,包括暗光环境。
Vivity 人工晶体全称AcrySof IQ Vivity®Toric IOL,是美国爱尔康公司生产的新一代老视矫正型人工晶状体,2023年9月在国内上市,是全球首款采用非衍射型波前重塑技术的景深延长型人工晶状体,也是全球首个采用波前重塑技术的老视矫正人工晶状体。 ▲源于山西爱尔眼科...
The article offers information about the AcrySof Toric IOL. It states that the technology is an alternative that can deliver safely precise way to correct astigmatism. It is a method that manages the disor...
AcrySof IQ Vivity Extended Vision IOLs deliver distance, intermediate, & functional near vision for patients after cataract surgery.
而且能获得良好的近视力。AcrySof IQ Vivity® Toric人工晶体还可以让合并角膜规则散光的患者享受清晰的连续视程。此次AcrySof IQ Vivity®Toric IOL在我院的顺利植入为我市带有散光的中老年白内障人群提供了更多选择，期待Vivity®Toric IOL在未来能够为更多白内障患者提供更优质的视觉质量和更舒适的视觉体验。
Acrysof IQ Toric人工晶状体矫正白内障患者角膜规则散光的临床观察 目的Acrysof IQ Toric人工晶状体(intraocular lens,IOL)可有效地降低白内障患者的角膜散光.比较植入Acrysof IQ Toric IOL后白内障患者手术前后的视觉质量.方法 选择2... 侯培莉,陆燕,叶芬,... - 《医学研究生学报》 被引量: 13发表: 2014年 OC...